CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-13 | POYHONEN JOHN President & CCO | Shares withheld for taxes | −2,012 | $6.07 | $12K | 31,440 |
| 2022-04-13 | POYHONEN JOHN President & CCO | Option exercise · Restricted Stock Units | −1,250 | 12,500 | ||
| 2022-04-13 | POYHONEN JOHN President & CCO | Option exercise · Restricted Stock Units | −4,564 | 46,192 | ||
| 2022-04-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +552 | 16,268 | ||
| 2022-04-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +1,932 | 18,200 | ||
| 2022-04-13 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −860 | $6.07 | $5K | 17,340 |
| 2022-04-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −552 | 5,521 | ||
| 2022-04-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −1,932 | 19,559 | ||
| 2022-04-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise | +1,250 | 8,320 | ||
| 2022-04-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise | +4,564 | 12,884 | ||
| 2022-04-13 | MANHARD KIMBERLY EVP, Drug Development | Shares withheld for taxes | −2,012 | $6.07 | $12K | 10,872 |
| 2022-04-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise · Restricted Stock Units | −1,250 | 12,500 | ||
| 2022-04-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise · Restricted Stock Units | −4,564 | 46,192 | ||
| 2022-01-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise | +1,250 | 5,231 | ||
| 2022-01-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise | +4,564 | 9,795 | ||
| 2022-01-13 | Szekeres David Leslie EVP, Chief Operating Officer | Shares withheld for taxes | −2,012 | $8.30 | $17K | 7,783 |
| 2022-01-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise · Restricted Stock Units | −1,250 | 13,750 | ||
| 2022-01-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise · Restricted Stock Units | −4,564 | 50,756 | ||
| 2022-01-13 | Quart Barry D Chief Executive Officer | Option exercise | +3,646 | 105,732 | ||
| 2022-01-13 | Quart Barry D Chief Executive Officer | Option exercise | +16,122 | 121,854 |
Page 22 of 28 · 557 trades